Filing Flows › Scientist Home Future Health (SHFH) › Q2 2026 › vs Q2 2025
Scientist Home Future Health (SHFH) Q2 2026 vs Q2 2025 (year over year)
Scientist Home Future Health's revenue rose $53K (+167%) from $32K in Q2 2025 to $84K in Q2 2026. The biggest changes: Others (Delivery Fee) +$38K (103×); Scientist Home Mixed Gelatine Hydrolysate −$5K (-40%); Scientist Home High Concentration Proteinase −$1K (-12%).
Scientist Home Future Health, Q2 2026: revenue $84K (+167% year over year), operating margin -116.1%, net loss $98K, operating cash flow −$13K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Others (Delivery Fee) | $38K | $368 | $38K | 103× |
| Scientist Home High Concentration Proteinase | $8K | $9K | −$1K | -12% |
| Scientist Home Mixed Gelatine Hydrolysate | $7K | $12K | −$5K | -40% |
| Revenue | $84K | $32K | $53K | +167% |
| Net loss | $98K | $37K | $61K | +163% |
| Costs & expenses | $182K | $70K | $112K | +161% |
| Operating costs | $182K | $70K | $112K | +161% |
| Cost of revenue | $55K | $18K | $37K | +206% |
| Operating expenses | $127K | $52K | $75K | +146% |
| Operating cash sources | $98K | $37K | $61K | +163% |
| Depreciation | $4K | $0 | $4K | — |
| Working capital & other | $81K | $32K | $49K | +155% |
| Cash used in operations | $13K | $5K | $8K | +143% |
| Net loss absorbed | $98K | $37K | $61K | +163% |
Questions
How much did Scientist Home Future Health's revenue grow year over year in Q2 2026?
Scientist Home Future Health's revenue rose $53K (+167%) from $32K in Q2 2025 to $84K in Q2 2026.
What drove Scientist Home Future Health's revenue change in Q2 2026?
Others (Delivery Fee) +$38K (103×); Scientist Home Mixed Gelatine Hydrolysate −$5K (-40%); Scientist Home High Concentration Proteinase −$1K (-12%).